Phase 3 Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Spinal cord injury group:
- Adults between 18 and 75 years old who have had a spinal cord injury at the neck level (between the C3 and C8 vertebrae)
- People who are at least 1 year past their injury date
- People taking muscle relaxant or anti-spasm medications must have been on a stable dose for at least 4 weeks before screening
Stroke group:
- Adults between 18 and 75 years old who have had any type of stroke that affected movement in their arm(s), with some movement still remaining
- People who are at least 6 months past their stroke
- People who have had Botox-type injections for muscle stiffness must be at least 4 months past their last injection, or within 2 months of finishing the study (confirm with trial site)
- People taking muscle relaxant or anti-spasm medications must have been on a stable dose for at least 4 weeks before screening
Who may not be able to join:
- Women who are pregnant
- People who have difficulty speaking or understanding language
- People with severe muscle stiffness, rated 3 or higher on a standard medical scale called the Modified Ashworth Scale
- People who have an implanted medical device, such as a pacemaker, defibrillator, deep brain stimulator, vagus nerve stimulator, eye implant, or medication pump
- People who have any conductive, magnetic, or metal implants in their head
- People with a personal history of seizures or epilepsy
- People taking any medication that is known to lower the threshold for seizures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jessica D'Amico, PhD, University of Alberta
Phone: 7807357917
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Spinal Excitability; Corticospinal excitability; Clinical assessment of UE function; Changes in Intracortical Excitability
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.